Teladoc Stock Net Income
| 4LL Stock | EUR 4.05 0.03 0.75% |
As of the 7th of February, Teladoc has the Coefficient Of Variation of (413.92), variance of 12.29, and Risk Adjusted Performance of (0.19). Teladoc technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Teladoc variance, treynor ratio, and the relationship between the standard deviation and information ratio to decide if Teladoc is priced more or less accurately, providing market reflects its prevalent price of 4.05 per share.
Teladoc Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.4696 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -901.1 M | -946.2 M | |
| Net Loss | -12.3 B | -11.7 B | |
| Net Loss | -901.1 M | -946.2 M | |
| Net Loss | (6.75) | (7.09) | |
| Net Income Per E B T | 1.16 | 1.09 |
Teladoc | Net Income |
The Net Income trend for Teladoc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Teladoc is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Teladoc's Net Income Growth Pattern
Below is the plot of the Net Income of Teladoc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Teladoc financial statement analysis. It represents the amount of money remaining after all of Teladoc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Teladoc's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Teladoc's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (1 B) | 10 Years Trend |
|
Net Income |
| Timeline |
Teladoc Net Income Regression Statistics
| Arithmetic Mean | (1,086,153,649) | |
| Coefficient Of Variation | (299.91) | |
| Mean Deviation | 1,479,220,865 | |
| Median | (98,864,000) | |
| Standard Deviation | 3,257,434,587 | |
| Sample Variance | 10610880.1T | |
| Range | 13.6B | |
| R-Value | (0.29) | |
| Mean Square Error | 10392380.7T | |
| R-Squared | 0.08 | |
| Significance | 0.27 | |
| Slope | (184,499,663) | |
| Total Sum of Squares | 169774081.5T |
Teladoc Net Income History
Teladoc Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Teladoc is extremely important. It helps to project a fair market value of Teladoc Stock properly, considering its historical fundamentals such as Net Income. Since Teladoc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Teladoc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Teladoc's interrelated accounts and indicators.
Click cells to compare fundamentals
Teladoc 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Teladoc's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Teladoc.
| 11/09/2025 |
| 02/07/2026 |
If you would invest 0.00 in Teladoc on November 9, 2025 and sell it all today you would earn a total of 0.00 from holding Teladoc or generate 0.0% return on investment in Teladoc over 90 days. Teladoc is related to or competes with Novavax, and Bonesupport Holding. Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and inter... More
Teladoc Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Teladoc's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Teladoc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.27) | |||
| Maximum Drawdown | 21.06 | |||
| Value At Risk | (7.34) | |||
| Potential Upside | 3.45 |
Teladoc Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Teladoc's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Teladoc's standard deviation. In reality, there are many statistical measures that can use Teladoc historical prices to predict the future Teladoc's volatility.| Risk Adjusted Performance | (0.19) | |||
| Jensen Alpha | (0.97) | |||
| Total Risk Alpha | (1.20) | |||
| Treynor Ratio | (0.62) |
Teladoc February 7, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.19) | |||
| Market Risk Adjusted Performance | (0.61) | |||
| Mean Deviation | 2.48 | |||
| Coefficient Of Variation | (413.92) | |||
| Standard Deviation | 3.51 | |||
| Variance | 12.29 | |||
| Information Ratio | (0.27) | |||
| Jensen Alpha | (0.97) | |||
| Total Risk Alpha | (1.20) | |||
| Treynor Ratio | (0.62) | |||
| Maximum Drawdown | 21.06 | |||
| Value At Risk | (7.34) | |||
| Potential Upside | 3.45 | |||
| Skewness | 0.8085 | |||
| Kurtosis | 3.84 |
Teladoc Backtested Returns
Teladoc owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.23, which indicates the firm had a -0.23 % return per unit of risk over the last 3 months. Teladoc exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Teladoc's Risk Adjusted Performance of (0.19), variance of 12.29, and Coefficient Of Variation of (413.92) to confirm the risk estimate we provide. The entity has a beta of 1.39, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Teladoc will likely underperform. At this point, Teladoc has a negative expected return of -0.79%. Please make sure to validate Teladoc's jensen alpha, treynor ratio, and the relationship between the standard deviation and total risk alpha , to decide if Teladoc performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.53 |
Good reverse predictability
Teladoc has good reverse predictability. Overlapping area represents the amount of predictability between Teladoc time series from 9th of November 2025 to 24th of December 2025 and 24th of December 2025 to 7th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Teladoc price movement. The serial correlation of -0.53 indicates that about 53.0% of current Teladoc price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.53 | |
| Spearman Rank Test | -0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 0.62 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Teladoc Net Interest Income
Net Interest Income |
|
Based on the recorded statements, Teladoc reported net income of (1 Billion). This is 393.38% lower than that of the Health Care Technology sector and significantly lower than that of the Health Care industry. The net income for all Germany stocks is significantly higher than that of the company.
Teladoc Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Teladoc's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Teladoc could also be used in its relative valuation, which is a method of valuing Teladoc by comparing valuation metrics of similar companies.Teladoc is currently under evaluation in net income category among its peers.
Teladoc Current Valuation Drivers
We derive many important indicators used in calculating different scores of Teladoc from analyzing Teladoc's financial statements. These drivers represent accounts that assess Teladoc's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Teladoc's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 18.1B | 14.4B | 3.8B | 3.5B | 3.1B | 5.7B | |
| Enterprise Value | 18.8B | 14.8B | 4.5B | 4.0B | 3.6B | 5.9B |
Teladoc Fundamentals
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.0348 | ||||
| Profit Margin | (0.09) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 1 B | ||||
| Shares Outstanding | 177.47 M | ||||
| Shares Owned By Insiders | 1.01 % | ||||
| Shares Owned By Institutions | 72.18 % | ||||
| Price To Book | 0.65 X | ||||
| Price To Sales | 0.29 X | ||||
| Revenue | 2.57 B | ||||
| Gross Profit | 1.76 B | ||||
| EBITDA | 16.17 M | ||||
| Net Income | (1 B) | ||||
| Cash And Equivalents | 722.63 M | ||||
| Cash Per Share | 4.68 X | ||||
| Total Debt | 550.72 M | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 3.96 X | ||||
| Book Value Per Share | 6.65 X | ||||
| Cash Flow From Operations | 293.68 M | ||||
| Earnings Per Share | (0.99) X | ||||
| Target Price | 195.48 | ||||
| Number Of Employees | 4.62 K | ||||
| Beta | 2.14 | ||||
| Market Capitalization | 738.72 M | ||||
| Total Asset | 3.52 B | ||||
| Retained Earnings | (16.23 B) | ||||
| Working Capital | 722.37 M | ||||
| Net Asset | 3.52 B |
About Teladoc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Teladoc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Teladoc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Teladoc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more detail on how to invest in Teladoc Stock please use our How to Invest in Teladoc guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.